Lilly has been instrumental in supplying its API for insulin at a low cost and offering technology transfer to EVA.

The collaboration of Lilly and EVA Pharma began in 2022 to provide affordable insulin. Credit: © 2022 Eva Pharma All Rights Reserved. Eli Lilly and EVA Pharma have ...

Insulin therapy, vital for diabetes management, is often misunderstood. It's not a sign of failure or addiction, nor does it ...

Eli Lilly and Company said the Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a ...

This episode of the Home Alone Alliance series on managing medications shows a family caregiver learning how to inject insulin, a medication used to treat diabetes. The video shows the family ...

Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection ...

Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in control. Cipla is introducing ...

Myth 6: Insulin injections hurt a lot The truth: Thanks to advances in technology, insulin delivery is far more comfortable and convenient than ever. Insulin pens with ultra-fine needles and pre ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

(RTTNews) - Eli Lilly and Company said the Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly (LLY). The ...

This milestone stems from the companies’ collaboration to expand access to affordable insulin to one million people living ...